methylprednisolone has been researched along with Demyelinating Diseases in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (8.79) | 18.7374 |
1990's | 20 (21.98) | 18.2507 |
2000's | 24 (26.37) | 29.6817 |
2010's | 32 (35.16) | 24.3611 |
2020's | 7 (7.69) | 2.80 |
Authors | Studies |
---|---|
Begum, Z; Gurusamy, K; Raghunath, G; Sivanesan, S; Subramanian, V; Vijayaraghavan, R | 1 |
Araki, A; Fuse, K; Morozumi, S; Yasui, K | 1 |
Abe, Y; Hayakawa, I; Mutoh, T; Ochiai, S | 1 |
Abdallah, A; Ata, F; Sharif, MK; Yousaf, Z | 1 |
Cleanthous, M; Kinnis, E; Kyriakides, T; Lambrianides, S; Leonidou, E; Myrianthopoulou, P | 1 |
Hemingway, C; Lim, M; Luchesa Smith, A; Sudarsan, N | 1 |
Gulati, S; Kapoor, A; Kumar, A; Sinha, R; Wander, A; Yadav, R | 1 |
Manners, J; Marker, D; Mettenburg, J; Murdoch, G; Stevens, B; Thomas, DL; Wang, G; Wiley, C | 1 |
Kanda, T; Kawai, M; Koga, M; Maeda, T; Ogasawara, JI; Omoto, M; Sano, H | 1 |
Akiyama, H; Hasegawa, Y; Hoshino, M; Mutoh, T; Shima, S; Suzuki, Y; Yamada, K | 1 |
Chetty, S; Kobayter, L | 1 |
Azizi, M; Borhani-Haghighi, M; Kashani, IR; Madadi, S; Nekoonam, S; Noorzehi, G; Pasbakhsh, P; Tahmasebi, F | 1 |
Das, SK; Denny, AM | 1 |
Almalki, DM; Alsaman, AS; Mahmoud, AA; Mudhafar, OY | 1 |
Ellenberger, D; Friede, T; Gärtner, J; Huppke, B; Huppke, P; Koziolek, M; Mühlhausen, J; Müller, GA; Sigler, M | 1 |
Bendszus, M; Diem, R; Lanz, T; Platten, M | 1 |
Maramattom, BV; Thomas, J | 1 |
Alonso, B; de Andrés, C; Faure, F; Mateos, D; Ramos-Medina, R; Sánchez-Ramón, S; Teijeiro, R; Tejera-Alhambra, M; Valor, L | 1 |
Higuchi, K; Kitazawa, K; Koshihara, H; Oguchi, K; Ohara, S; Takei, Y | 1 |
Aoki, M; Fujihara, K; Ikeda, K; Kiyota, N; Kuroda, H; Misu, T; Nakashima, I; Nishiyama, S; Sato, DK; Takahashi, T | 1 |
Dast Borhan, Z; Dehghani, A; Mirmohammadsadeghi, A; Rahimi, M; Shahzamani, S; Shayegannejad, V | 1 |
Akingbola, O; Armstrong, C; Dawson, E; Maatouk, O; Nelson, S; Singh, D | 1 |
Huang, Q; Liu, X; Wei, X; Wu, Y | 1 |
Gallo, P; Miante, S; Perini, P; Rinaldi, F | 1 |
Miranda, MJ; Olofsson, IA; Skov, L | 1 |
Davila-Acosta, J; Pohl, D; Thulasirajah, S; Venkateswaran, S | 1 |
Banwell, B; Narula, S | 1 |
Hamano, S; Hara, T; Hirabayashi, S; Ichiyama, T; Ishizaki, Y; Kimura, S; Kira, J; Kira, R; Kishi, T; Kubota, M; Kusunoki, S; Maegaki, Y; Minagawa, K; Mizuguchi, M; Natsume, J; Oka, A; Sakai, Y; Sanefuji, M; Takahashi, Y; Takanashi, J; Tamai, H; Torisu, H; Yamaguchi, Y; Yoshikawa, H | 1 |
Fujimura, H; Fukada, K; Hazama, T; Inoue, K; Kinoshita, M; Sugimura, Y | 1 |
Kira, JI; Koda, T; Mochizuki, H; Nakatsuji, Y; Ogata, H; Shimizu, M | 1 |
Annunziata, P; Battisti, C; Cioni, C; Federico, A; Mignarri, A; Tumminelli, G | 1 |
Amalnath, SD; Hamide, A; Narayana, BS; Sahoo, R | 1 |
Hirata, K; Hoshino, Y; Odaka, M | 1 |
Arnold, DL; Awuku, M; Baird, JB; Banwell, B; Bar-Or, A; Bhan, V; Buckley, D; Connolly, MB; Cooper, P; Dilenge, ME; Doja, A; Grand'Maison, F; Guimond, C; Kennedy, J; Levin, S; Lortie, A; Lowry, N; MacDonald, EA; Magalhaes, S; Mah, JK; Meaney, B; Meek, D; Sadovnick, D; Sebire, G; Shah, N; Wambera, K; Whiting, S; Wood, E; Yager, J; Yim, C | 1 |
Dastgir, J; DiMario, FJ | 1 |
Deore, RA; Nadkar, MY; Singh, R | 1 |
González-Martín-Moro, J; Moreno-Martín, P; Pilo-de-la-Fuente, B | 1 |
Inoue, K; Kutoku, Y; Murakami, T; Sunada, Y | 1 |
Fujihara, K; Itoyama, Y; Misu, T; Sato, S; Takahashi, T; Takano, R | 1 |
Cate, HS; Egan, GF; Fang, K; Kemper, D; Kilpatrick, TJ; Merlo, D; Wang, HX; Wu, QZ | 1 |
Börnsen, L; Khademi, M; Olsson, T; Sellebjerg, F; Sørensen, PS | 1 |
Beyer, C; Clarner, T; Kipp, M; Parabucki, A | 1 |
Haginoya, K; Hino-Fukuyo, N; Hirose, M; Kakisaka, Y; Kobayashi, T; Numata, Y; Tsuchiya, S; Uematsu, M | 1 |
Anto, V; Rajasekharan, C; Unnikrishnan, R | 1 |
Lakhan, SE | 1 |
Allen, SH; Johnson, MA; Lipman, MC; Malik, O; Wilson, LA | 1 |
Braff, S; Mao-Draayer, Y; Panitch, H; Pendlebury, W | 1 |
Calabresi, P; Desiato, MT; Floris, R; Massa, R; Panico, MB; Rizzo, C | 1 |
Boz, C; Ozmenoglu, M; Velioglu, S | 1 |
Els, T; Gerlach, A; Glocker, FX; Oehm, E; Wattchow, J; Ziyeh, S | 1 |
CHRISTY, NP; FISHMAN, RA | 1 |
KIBLER, RF | 2 |
Brinar, VV | 1 |
Beatty, RL; Bhatti, MT; Schmitt, NJ | 1 |
Conceição, I; Couto, M; de Carvalho, M | 1 |
Khot, S; Lacy, JM; Longstreth, WT; Oakes, P; Walker, M | 1 |
Arias, M; Arias-Rivas, S; Dapena, D; Santos-García, D | 1 |
Ceulemans, B; De Weerdt, A; Jorens, PG; Laridon, A; Mertens, G; Parizel, PM; Wojciechowski, M | 1 |
Anagnostou, E; Anastasopoulos, D; Varaki, K | 1 |
Bosch, VV; Cook, SD; Dowling, PC | 1 |
Maegaki, Y; Takeshita, K; Tohyama, J | 1 |
Lee, AG | 1 |
Chinchilla, D; Dulac, O; Graber, D; Pinel, JF; Plouin, P; Ponsot, G; Robain, O | 1 |
Bartleson, JD; Karnes, WE; Pineda, AA; Rodriguez, M | 1 |
Barkhof, F; Borm, GF; Frequin, ST; Hommes, OR; Jongen, PJ; Lamers, KJ | 1 |
Baba, M; Hishida, R; Matsunaga, M; Shimamura, H; Takebe, K | 1 |
Forrer, A; Job, O; Killer, HE | 1 |
Kimura, J | 1 |
Kato, S; Komori, T; Sakai, K; Tanabe, H | 1 |
Abe, K; Fujimoto, T; Fujimura, H; Kawata, S; Kayanoki, Y; Matsuzawa, Y; Nagano, S; Oshikawa, O; Sugai, F; Yamasaki, E; Yanagihara, T | 1 |
Deguchi, K; Takeuchi, H; Tsukaguchi, M; Yamada, A; Yuki, N | 1 |
Chen, JM; Commins, DJ | 1 |
Hamata, M; Kobayashi, S; Kotani, I; Murakami, M; Okada, K; Seki, T | 1 |
Pavelko, KD; Rodriguez, M; van Engelen, BG | 1 |
Hanaoka, N; Hanyu, N; Yanagisawa, N | 1 |
Cevoli, S; Liguori, R; Lugaresi, A; Montagna, P; Rizzi, R; Salvi, F; Vetrugno, R | 1 |
Fujimoto, S; Inobe, J; Kamiyama, H; Kumamoto, H; Mori, T; Nagatomi, F; Sannomiya, K; Sugihara, R; Tsuda, T | 1 |
Okamoto, K; Sotomatsu, A; Tanaka, M; Yoshida, T | 1 |
Cigdem Dogulu, F; Firat, M; Karabudak, R; Ruacan, S; Saygi, S; Unal, I | 1 |
Belin, C; Brauner, M; Chapelon-Abric, C; Dumas, JL; Goldlust, D; Piette, JC; Tandjaoui-Lambiotte, H; Valeyre, D | 1 |
Cendes, F; Damasceno, BP; Kobayashi, E; Maciel, EP; Netto, JR; Reis, F; Zanardi, Vde A | 1 |
Khan, OA; Rothman, MI | 1 |
Friedman, DI | 1 |
Kikkawa, Y; Niwa, N; Takaya, Y | 1 |
Baraczka, K; Lakos, G; Sipka, S | 1 |
McKenzie, B; Stabback, S; Yeo, JD | 1 |
Matsumoto, A; Naganuma, M; Shima, K; Tashiro, K | 1 |
Castro-Gago, M; Rodriguez-Núñez, A | 1 |
Iwatsubo, T; Obi, T; Sakanaka, C; Sakuta, M; Takeda, K | 1 |
Nelson, DA | 1 |
10 review(s) available for methylprednisolone and Demyelinating Diseases
Article | Year |
---|---|
Diagnosis and management of multiple sclerosis and other relapsing demyelinating disease in childhood.
Topics: Adolescent; Anti-Inflammatory Agents; Brain; Child; Demyelinating Diseases; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neuromyelitis Optica; Occupational Therapy; Recurrence | 2022 |
[Clinically isolated syndrome].
Topics: Adult; Brain; Demyelinating Diseases; Diagnosis, Differential; Glatiramer Acetate; Guideline Adherence; Humans; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Optic Neuritis; Peptides; Prognosis; Pulse Therapy, Drug; Spinal Cord; Young Adult | 2013 |
Asymptomatic Mycoplasma Infection Causing Acute Demyelinating Encephalomyelitis: Case Report and Review of Literature.
Topics: Acute Disease; Anti-Inflammatory Agents; Brain; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Electroencephalography; Encephalomyelitis; Humans; Immunoglobulins; Magnetic Resonance Imaging; Male; Methylprednisolone; Mycoplasma Infections; Plasmapheresis | 2016 |
[Demyelinating diseases in children with acute neurological symptoms].
Topics: Child; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Neuromyelitis Optica; Neuroprotective Agents; Optic Neuritis | 2015 |
Pediatric Demyelination.
Topics: Child; Child, Preschool; Demyelinating Diseases; Encephalomyelitis, Acute Disseminated; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Neuromyelitis Optica | 2016 |
Non-MS recurrent demyelinating diseases.
Topics: Adult; Anti-Inflammatory Agents; Atrophy; Brain; Demyelinating Diseases; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Recurrence; Reflex, Abnormal; Tongue | 2004 |
[Retrobulbar neuritis--diagnosis and differential diagnosis].
Topics: Central Nervous System Diseases; Demyelinating Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Humans; Methylprednisolone; Neurologic Examination; Optic Neuritis; Peripheral Nervous System Diseases; Steroids | 1996 |
[Electrophysiological diagnosis and therapy of peripheral nerve demyelinating diseases].
Topics: Anti-Inflammatory Agents; Demyelinating Diseases; Electromyography; Electrophysiology; Humans; Immunoglobulins; Immunosorbent Techniques; Methylprednisolone; Neural Conduction; Peripheral Nervous System Diseases | 1996 |
Multiple sclerosis simulating a mass lesion.
Topics: Adult; Blood Sedimentation; Brain; Brain Diseases; Demyelinating Diseases; Dexamethasone; Female; Glucocorticoids; Hemianopsia; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Paresis; Pregnancy; Stereotaxic Techniques | 2000 |
Dangers from methylprednisolone acetate therapy by intraspinal injection.
Topics: Demyelinating Diseases; Humans; Injections, Epidural; Injections, Spinal; Intervertebral Disc; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis; Nervous System Diseases; Neurology; Polyethylene Glycols; Spinal Diseases; Spinal Nerve Roots | 1988 |
2 trial(s) available for methylprednisolone and Demyelinating Diseases
Article | Year |
---|---|
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Topics: Acute Disease; Adolescent; Adult; Demyelinating Diseases; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Nerve Fibers; Optic Neuritis; Recombinant Proteins; Retinal Ganglion Cells; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2015 |
[Retrobulbar neuritis--diagnosis and differential diagnosis].
Topics: Central Nervous System Diseases; Demyelinating Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Humans; Methylprednisolone; Neurologic Examination; Optic Neuritis; Peripheral Nervous System Diseases; Steroids | 1996 |
80 other study(ies) available for methylprednisolone and Demyelinating Diseases
Article | Year |
---|---|
Efficacy of different intensity of aquatic exercise in enhancing remyelination and neuronal plasticity using cuprizone model in male Wistar rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Basic Protein; Neuronal Plasticity; Neuroprotective Agents; Rats; Rats, Wistar; Remyelination | 2022 |
[A patient with anti-myelin oligodendrocyte glycoprotein antibody-associated combined central and peripheral demyelination with anti-galactocerebroside and anti-GM1 antibodies].
Topics: Autoantibodies; Demyelinating Diseases; Humans; Immunoglobulin G; Male; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Myelitis; Oligodendroglia | 2023 |
Pediatric anti-neutral glycosphingolipid antibodies-positive encephalomyeloradiculoneuropathy presenting with prominent brain demyelination.
Topics: Adult; Autoantibodies; Brain; Child; Child, Preschool; Demyelinating Diseases; Glycosphingolipids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone | 2023 |
Demyelinating steroid-responsive neurobrucellosis.
Topics: Adult; Anti-Bacterial Agents; Brain Diseases; Brucellosis; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Methylprednisolone; Prednisolone | 2020 |
A Case of Combined Central and Peripheral Demyelination Associated With Antineurofascin 155 Antibodies and Paternal History of Multiple Sclerosis.
Topics: Adult; Demyelinating Diseases; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Rituximab | 2021 |
Acute Demyelinating Syndrome (MOG Antibody Positive) Associated With COVID-19 Infection: A Widening spectrum.
Topics: Acute Disease; Brain; Child; COVID-19; COVID-19 Drug Treatment; Demyelinating Diseases; Female; Glucocorticoids; Humans; Immunoglobulins; Magnetic Resonance Imaging; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Optic Nerve; Prednisolone; SARS-CoV-2; Spinal Cord; Syndrome | 2021 |
CD8-Positive T-Cell Leukoencephalitis With Astrocytopathy Clinically Presenting as Neuromyelitis Optica.
Topics: Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Astrocytes; Autopsy; CD8-Positive T-Lymphocytes; Demyelinating Diseases; Encephalitis; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Spinal Cord; White Matter | 2017 |
Steroid-responsive demyelinating peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells.
Topics: Administration, Oral; Aged; Biomarkers; Chronic Disease; Demyelinating Diseases; Female; Humans; Killer Cells, Natural; Lymphoproliferative Disorders; Methylprednisolone; Peripheral Nervous System Diseases; Prednisolone; Pulse Therapy, Drug; Receptors, IgG; Sural Nerve; Treatment Outcome | 2017 |
[Efficacy of high-dose steroid pulse therapy for anti-galactocerebroside antibody-positive combined central and peripheral demyelination].
Topics: Autoantibodies; Biomarkers; Cell Adhesion Molecules; Central Nervous System Diseases; Demyelinating Diseases; Galactosylceramides; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Myelin Basic Protein; Nerve Growth Factors; Peripheral Nervous System Diseases; Pulse Therapy, Drug; Treatment Outcome | 2017 |
Management of optic neuritis in Ireland: a survey comparing the management practices of acute demyelinating optic neuritis amongst ophthalmologists and neurologists in Ireland.
Topics: Acute Disease; Clinical Laboratory Techniques; Demyelinating Diseases; Female; Glucocorticoids; Health Care Surveys; Humans; Ireland; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neurologists; Ophthalmologists; Optic Neuritis; Practice Patterns, Physicians' | 2019 |
Microglia polarization by methylprednizolone acetate accelerates cuprizone induced demyelination.
Topics: Animals; Chemokine CXCL10; Cuprizone; Demyelinating Diseases; Inflammation; Methylprednisolone; Mice; Microglia; Multiple Sclerosis | 2018 |
A case of central nervous system vasculitis presenting as a mass-like lesion.
Topics: Adolescent; Brain Neoplasms; Demyelinating Diseases; Diagnosis, Differential; Glioma; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Neuroimaging; Treatment Outcome; Vasculitis, Central Nervous System | 2019 |
Diagnostic uncertainty of tumefactive cystic demyelinating lesions.
Topics: Brain; Child; Demyelinating Diseases; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Methylprednisolone Acetate; Nerve Fibers, Myelinated; Treatment Outcome | 2013 |
Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating disease.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Child; Demyelinating Diseases; Humans; Inflammation; Male; Methylprednisolone; Neuroprotective Agents; Plasma Exchange; Retrospective Studies; Treatment Outcome; Visual Acuity | 2013 |
Muckle Wells syndrome associated with multifocal clinically isolated syndrome.
Topics: Comorbidity; Cryopyrin-Associated Periodic Syndromes; Demyelinating Diseases; Female; Humans; Methylprednisolone; Treatment Outcome; Young Adult | 2014 |
New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids.
Topics: Adult; Antigens, CD19; B-Lymphocytes, Regulatory; Cross-Sectional Studies; Demyelinating Diseases; Female; Glucocorticoids; Granzymes; Humans; Interleukin-2 Receptor alpha Subunit; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Perforin; Recurrence; T-Lymphocytes, Regulatory; Young Adult | 2014 |
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
Topics: Anti-Inflammatory Agents; Brain; Demyelinating Diseases; Encephalomyelitis, Acute Disseminated; Female; Humans; Inflammation; Magnetic Resonance Imaging; Meninges; Methylprednisolone; Middle Aged; Treatment Outcome | 2014 |
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
Topics: Adult; Antibodies, Blocking; Astrocytes; Demyelinating Diseases; Glial Fibrillary Acidic Protein; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Myelitis, Transverse; Neuromyelitis Optica; Neuroprotective Agents | 2015 |
Dl-3-n-butylphthalide is effective for demyelination: a case-combined study.
Topics: Adult; Animals; Benzofurans; Brain; Demyelinating Diseases; Disease Models, Animal; Electroencephalography; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Radiography; Rats, Sprague-Dawley; Treatment Outcome | 2015 |
A case of relapsing-remitting tumour-like inflammation of the central nervous system.
Topics: Adult; Brain; Brain Neoplasms; Demyelinating Diseases; Encephalitis; Female; Glucocorticoids; Hemianopsia; Humans; Magnetic Resonance Imaging; Methylprednisolone; Recurrence; Syndrome | 2015 |
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Topics: Autoantibodies; Brain; Child; Child, Preschool; Demyelinating Diseases; Encephalomyelitis, Acute Disseminated; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Myelitis, Transverse; Neuromyelitis Optica; Retrospective Studies; Spinal Cord; Treatment Outcome | 2016 |
A nationwide survey of pediatric acquired demyelinating syndromes in Japan.
Topics: Child; Child, Preschool; Demyelinating Diseases; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Japan; Magnetic Resonance Imaging; Male; Methylprednisolone; Retrospective Studies; Steroids; Surveys and Questionnaires | 2016 |
An adult-onset multiphasic disseminated encephalomyelitis (MDEM) presenting favorable response to steroid therapy.
Topics: Administration, Oral; Azathioprine; Brain; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Edema; Encephalomyelitis, Acute Disseminated; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Treatment Outcome | 2016 |
A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange.
Topics: Adult; Autoantibodies; Biomarkers; Cell Adhesion Molecules; Central Nervous System Diseases; Demyelinating Diseases; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Nerve Growth Factors; Peripheral Nervous System Diseases; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Pulse Therapy, Drug; Treatment Outcome; Young Adult | 2017 |
Demyelinating polyneuropathy in a case of anti-LGI1 encephalitis.
Topics: Aged; Anti-Inflammatory Agents; Autoantibodies; Demyelinating Diseases; Encephalitis; Humans; Intracellular Signaling Peptides and Proteins; Male; Methylprednisolone; Polyneuropathies; Proteins | 2017 |
Acute demyelinating encephalitis due to Abrus precatorius poisoning--complete recovery after steroid therapy.
Topics: Abrin; Abrus; Acute Disease; Administration, Oral; Demyelinating Diseases; Encephalitis; Glucocorticoids; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Prednisone; Seeds; Treatment Outcome; Young Adult | 2008 |
[Pontine hemorrhage in a patient with type 1 renal tubular acidosis associated with osmotic demyelination syndrome].
Topics: Acidosis, Renal Tubular; Adult; Cerebral Hemorrhage; Demyelinating Diseases; Humans; Hypokalemia; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelinolysis, Central Pontine; Osmolar Concentration; Pons; Syndrome; Thyrotropin-Releasing Hormone; Treatment Outcome | 2008 |
Incidence of acquired demyelination of the CNS in Canadian children.
Topics: Adolescent; Age Distribution; Canada; Central Nervous System Diseases; Child; Child, Preschool; Demography; Demyelinating Diseases; Encephalomyelitis, Acute Disseminated; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Incidence; Infant; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelitis, Transverse; Optic Neuritis; Sex Distribution | 2009 |
Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal.
Topics: Acute Disease; Adolescent; Brain; Cyclophosphamide; Demyelinating Diseases; Facial Nerve Diseases; Frontal Lobe; Hemiplegia; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Nerve Fibers, Myelinated; Ocular Motility Disorders; Paresis; Pons; Recurrence; Treatment Outcome; Vertigo | 2009 |
Tumefactive demyelination.
Topics: Adult; Brain; Demyelinating Diseases; Diagnosis, Differential; Female; Glucocorticoids; Humans; Injections; Magnetic Resonance Imaging; Methylprednisolone; Prednisolone; Tomography, X-Ray Computed; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 2008 |
[Migraineous anterior optic ischemic neuropathy].
Topics: Anti-Inflammatory Agents; Cholesterol, HDL; Demyelinating Diseases; Diagnostic Errors; Frontal Lobe; Humans; Infarction; Magnetic Resonance Imaging; Male; Methylprednisolone; Migraine with Aura; Optic Disk; Optic Neuropathy, Ischemic; Risk Factors; Tomography, X-Ray Computed; Visual Field Tests; Young Adult | 2009 |
[Case of chronic progressive encephalo-myelo-radiculo-neuropathy].
Topics: Aged; Chronic Disease; Demyelinating Diseases; Disease Progression; Encephalomyelitis, Acute Disseminated; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Polyradiculoneuropathy; Pulse Therapy, Drug; Sural Nerve | 2010 |
Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Topics: Adult; Aged; Antibodies; Aquaporin 4; Astrocytes; Biomarkers; Central Nervous System; Demyelinating Diseases; Disability Evaluation; Encephalomyelitis, Acute Disseminated; Female; Follow-Up Studies; Glial Fibrillary Acidic Protein; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Nerve Growth Factors; Nervous System Diseases; Neurofilament Proteins; Neuromyelitis Optica; Neuroprotective Agents; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Statistics, Nonparametric | 2010 |
Influence of methylprednisolone on magnetic resonance and histological measures during cuprizone-induced demyelination.
Topics: Animals; Brain; Cuprizone; Demyelinating Diseases; Female; Glucocorticoids; Magnetic Resonance Imaging; Methylprednisolone; Mice; Mice, Inbred C57BL; Myelin Sheath; Nerve Fibers, Myelinated | 2010 |
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
Topics: Adult; Cross-Sectional Studies; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Osteopontin; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Up-Regulation | 2011 |
Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
Topics: Adrenal Cortex Hormones; Animals; Animals, Newborn; Cells, Cultured; Chelating Agents; Corpus Callosum; Cuprizone; Demyelinating Diseases; Dexamethasone; Drug Evaluation, Preclinical; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; Myelin Sheath; Nerve Regeneration; Oligodendroglia; Rats | 2011 |
[Case of a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome without pharyngeal palsy].
Topics: Child, Preschool; Demyelinating Diseases; Guillain-Barre Syndrome; Humans; Immunoglobulins; Male; Methylprednisolone; Neural Conduction; Paralysis; Peripheral Nerves; Pharynx; Pulse Therapy, Drug; Treatment Outcome | 2011 |
Tumefactive demyelination-to cracks the nut without cracking the pot.
Topics: Choline; Corpus Callosum; Demyelinating Diseases; Diagnosis, Differential; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Methylprednisolone; Middle Aged; Tomography, X-Ray Computed | 2012 |
Teaching neuroimages: MRI time lag with acute disseminated encephalomyelitis.
Topics: Aged; Anti-Inflammatory Agents; Atrophy; Biopsy; Brain; Dementia; Demyelinating Diseases; Diagnosis, Differential; Disease Progression; Encephalomyelitis, Acute Disseminated; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Neuroprotective Agents; Plasma Exchange; Stereotaxic Techniques; Time Factors; Treatment Outcome | 2012 |
Acute demyelinating encephalomyelitis (ADEM) in a patient with HIV infection.
Topics: Acute Disease; Anti-Inflammatory Agents; Demyelinating Diseases; Encephalomyelitis; HIV Infections; Humans; Male; Methylprednisolone; Treatment Outcome | 2002 |
Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange.
Topics: Adult; Demyelinating Diseases; Female; Humans; Infusions, Intravenous; Methylprednisolone; Plasma Exchange | 2002 |
Adrenomyeloneuropathy partially responsive to steroid pulse therapy.
Topics: Adrenoleukodystrophy; Adult; Cerebellum; Demyelinating Diseases; Humans; Male; Methylprednisolone; Paraparesis, Spastic; Peripheral Nerves; Recovery of Function; Treatment Outcome | 2002 |
Acute disseminated encephalomyelitis after bee sting.
Topics: Animals; Anti-Inflammatory Agents; Bees; Brain; Demyelinating Diseases; Encephalomyelitis, Acute Disseminated; Female; Humans; Insect Bites and Stings; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Radiography | 2003 |
Use of high-dose cortisone in a patient with Marchiafava-Bignami disease.
Topics: Aged; Alcohol-Related Disorders; Anti-Inflammatory Agents; Corpus Callosum; Demyelinating Diseases; Female; Follow-Up Studies; Hemoglobinuria, Paroxysmal; Humans; Magnetic Resonance Imaging; Methylprednisolone | 2003 |
FATE OF ADRENAL CORTICAL STEROIDS FOLLOWING INTRATHECAL INJECTION.
Topics: Adrenal Cortex Hormones; Animals; Biological Transport; Blood Chemical Analysis; Blood-Brain Barrier; Cerebrospinal Fluid; Demyelinating Diseases; Dogs; Drug Therapy; Hydrocortisone; Injections; Injections, Spinal; Metabolism; Methylprednisolone; Multiple Sclerosis; Research | 1965 |
INTRODUCTORY REMARKS: SUPPRESSION OF DEMYELINATING DISEASE.
Topics: Demyelinating Diseases; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Methylprednisolone; Pharmacology | 1965 |
LARGE DOSE CORTICOSTEROID THERAPY OF EXPERIMENTAL AND HUMAN DEMYELINATING DISEASES.
Topics: Adrenal Cortex Hormones; Animals; Demyelinating Diseases; Drug Therapy; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Humans; Methylprednisolone; Multiple Sclerosis; Prednisone; Rabbits | 1965 |
Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management.
Topics: Acute Disease; Adult; Demyelinating Diseases; Diagnosis, Differential; Drug Administration Routes; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Optic Nerve; Optic Neuritis; Prednisolone; Visual Acuity | 2005 |
Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Demyelinating Diseases; Evoked Potentials, Somatosensory; Female; Hepatitis C; Humans; Interferon-alpha; Methylprednisolone; Middle Aged; Neural Conduction; Neuroprotective Agents; Polyradiculoneuropathy; Prednisone; Ribavirin | 2006 |
An unsuccessful trial of immunomodulatory therapy in delayed posthypoxic demyelination.
Topics: Alcoholic Intoxication; Demyelinating Diseases; Humans; Hypoxia, Brain; Male; Methylprednisolone; Middle Aged; Morphine Dependence; Neuroprotective Agents; Plasmapheresis; Treatment Failure | 2007 |
[Past hepatitis B virus infection and demyelinating multiphasic disease: casual or causal relationship?].
Topics: Aged; Cerebrospinal Fluid; Demyelinating Diseases; Diplopia; Encephalomyelitis; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukocytosis; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelitis, Transverse; Recurrence; Remission Induction; Urinary Retention | 2007 |
Streptococcus pneumoniae meningoencephalitis with unusual and widespread white matter lesions.
Topics: Anti-Inflammatory Agents; Brain; Brain Edema; Contrast Media; Demyelinating Diseases; Female; Humans; Infant; Magnetic Resonance Imaging; Meningoencephalitis; Methylprednisolone; Pneumococcal Infections; Respiratory Sounds; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed; Vasculitis, Central Nervous System | 2008 |
A minute demyelinating lesion causing acute positional vertigo.
Topics: Acute Disease; Anti-Inflammatory Agents; Cerebellar Nuclei; Demyelinating Diseases; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Nystagmus, Physiologic; Vertigo; Vestibule, Labyrinth; Vomiting | 2008 |
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.
Topics: Acute Disease; Adolescent; Adrenocorticotropic Hormone; Adult; Demyelinating Diseases; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Myelitis; Myelitis, Transverse; Polyradiculoneuropathy; Prednisone | 1980 |
[A case of early-onset and slowly progressive chronic inflammatory demyelinating polyneuropathy--electrophysiological findings with clinical course].
Topics: Adolescent; Age of Onset; Chronic Disease; Demyelinating Diseases; Disease Progression; Electrophysiology; Female; gamma-Globulins; Humans; Infusions, Intravenous; Median Nerve; Methylprednisolone; Neural Conduction; Polyneuropathies; Prednisolone | 1994 |
Familial pars planitis.
Topics: Administration, Oral; Adult; Cavernous Sinus; Demyelinating Diseases; Female; Humans; Injections, Intravenous; Meningeal Neoplasms; Meningioma; Methylprednisolone; Pars Planitis; Prednisolone; Visual Acuity | 1995 |
Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids.
Topics: Adolescent; Age of Onset; Biopsy; Brain; Child; Child, Preschool; Demyelinating Diseases; Epilepsies, Partial; Female; Frontal Lobe; Hemiplegia; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Occipital Lobe | 1994 |
Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination.
Topics: Adult; Demyelinating Diseases; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Plasmapheresis; Retrospective Studies; Treatment Outcome | 1993 |
T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Topics: Adrenal Cortex Hormones; Adult; B-Lymphocytes; Cerebrospinal Fluid; Chronic Disease; Demyelinating Diseases; Female; Humans; Injections, Intravenous; Intervertebral Disc Displacement; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; T-Lymphocytes | 1993 |
[Rapid recovery of chronic inflammatory demyelinating polyneuropathy induced by steroid pulse therapy--changes in nerve conduction].
Topics: Chronic Disease; Demyelinating Diseases; Female; Humans; Methylprednisolone; Middle Aged; Neural Conduction; Polyneuropathies; Prednisolone | 1993 |
[Infantile onset chronic inflammatory demyelinating polyneuropathy with clinical course of 23 years; a case report].
Topics: Adult; Age of Onset; Anti-Inflammatory Agents; Chronic Disease; Demyelinating Diseases; Diagnosis, Differential; Female; Humans; Methylprednisolone; Neural Conduction; Peripheral Nerves; Polyneuropathies; Prednisolone; Sural Nerve | 1996 |
Chronic inflammatory demyelinating polyneuropathy accompanied by hepatocellular carcinoma.
Topics: Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Demyelinating Diseases; Humans; Liver Neoplasms; Male; Methylprednisolone; Middle Aged; Neural Conduction; Paraneoplastic Syndromes; Polyneuropathies | 1997 |
[A case of chronic inflammatory demyelinating neuropathy associated with antibodies to gangliosides GM1 and GalNAc-GD1a].
Topics: Acetylgalactosamine; Anti-Inflammatory Agents; Autoantibodies; Chronic Disease; Demyelinating Diseases; G(M1) Ganglioside; Humans; Male; Methylprednisolone; Middle Aged; Prednisolone; Recurrence | 1997 |
Multiple sclerosis: a consideration in acute cranial nerve palsies.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Brain Stem; Demyelinating Diseases; Female; Hearing Loss, Sensorineural; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Paralysis; Severity of Illness Index; Vestibular Nerve; Vestibulocochlear Nerve | 1997 |
[Case of Wernicke's encephalopathy complicated with Marchiafava-Bignami syndrome].
Topics: Alcoholism; Anti-Inflammatory Agents; Corpus Callosum; Demyelinating Diseases; Humans; Male; Methylprednisolone; Middle Aged; Thiamine; Wernicke Encephalopathy | 1997 |
Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.
Topics: Animals; Antibodies, Monoclonal; Autoantibodies; Buffers; Demyelinating Diseases; Glucocorticoids; Image Processing, Computer-Assisted; Immunoglobulin G; Lysophosphatidylcholines; Macrophages; Methylprednisolone; Mice; Mice, Inbred Strains; Myelin Sheath; Phosphates; Spinal Cord; Thymidine; Tritium | 1998 |
[Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study].
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Chronic Disease; Combined Modality Therapy; Demyelinating Diseases; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Plasmapheresis; Polyradiculoneuropathy; Prednisolone | 1998 |
Steroid-responsive multifocal demyelinating neuropathy with central involvement.
Topics: Adult; Central Nervous System Diseases; Demyelinating Diseases; Electrodiagnosis; Evoked Potentials, Motor; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Prednisone | 1999 |
[Case of chronic inflammatory demyelinating polyneuropathy with its onset during infancy].
Topics: Adolescent; Age of Onset; Chronic Disease; Demyelinating Diseases; Humans; Infant; Inflammation; Male; Methylprednisolone; Peripheral Nervous System Diseases | 1999 |
Effect of methylprednisolone-pulse therapy on superoxide production of neutrophils.
Topics: Adult; Anti-Inflammatory Agents; Demyelinating Diseases; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neutrophils; Superoxides; Tetradecanoylphorbol Acetate | 1999 |
Multiphasic disseminated encephalomyelitis: a 4-year follow-up.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Brain; Demyelinating Diseases; Diagnosis, Differential; Encephalomyelitis; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Tomography, X-Ray Computed | 2000 |
Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy.
Topics: Adult; Brain; Brain Diseases; Contrast Media; Demyelinating Diseases; Disease Progression; Female; Follow-Up Studies; Gadolinium; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuroprotective Agents; Prednisone; Recurrence; Remission Induction; Sarcoidosis; Spinal Cord; Spinal Cord Diseases | 2000 |
[Magnetic resonance imaging and clinical features in adults with monophasic demyelinating disease. Acute disseminated encephalomyelitis or a variant of multiple sclerosis?].
Topics: Acute Disease; Adult; Demyelinating Diseases; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Retrospective Studies | 1999 |
Reversibility of acute demyelinating lesions in relapsing-remitting multiple sclerosis.
Topics: Adult; Brain; Demyelinating Diseases; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Remission Induction; Severity of Illness Index | 2000 |
[A case of Marchiafava-Bignami disease that responded to high-dose intravenous corticosteroid administration].
Topics: Alcohol-Related Disorders; Corpus Callosum; Demyelinating Diseases; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Wernicke Encephalopathy | 2000 |
Immunoserological changes in the cerebro-spinal fluid and serum in systemic lupus erythematosus patients with demyelinating syndrome and multiple sclerosis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Atrophy; Brain; Demyelinating Diseases; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Immunoglobulins; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prospective Studies | 2002 |
Central necrosis following contusion to the sheep's spinal cord.
Topics: Animals; Contusions; Demyelinating Diseases; Hyperbaric Oxygenation; Injections, Spinal; Methylprednisolone; Movement; Necrosis; Sheep; Spinal Cord; Spinal Cord Injuries; Tyrosine | 1977 |
Chronic multifocal demyelinating neuropathy associated with central nervous system demyelination.
Topics: Adult; Chronic Disease; Demyelinating Diseases; Electromyography; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Neural Conduction; Prednisolone; Recurrence; Spinal Cord | 1991 |
High-dose intravenous methyl-prednisolone in chronic relapsing dysimmune polyneuropathy (CRDP)
Topics: Child, Preschool; Chronic Disease; Demyelinating Diseases; Dose-Response Relationship, Drug; Female; Humans; Methylprednisolone; Peripheral Nervous System Diseases | 1989 |
[Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy].
Topics: Acute Disease; Chronic Disease; Demyelinating Diseases; Female; Humans; Methylprednisolone; Middle Aged; Plasma Exchange; Polyradiculoneuropathy; Prednisolone; Recurrence; Remission Induction | 1989 |